Association between the GRM7 rs3792452 polymorphism and attention deficit hyperacitiveity disorder in a Korean sample

Behavioral and Brain Functions

Volumn 9, Issue 1, 2013, Pages

  Park, Subin ^a   Jung, Sun Woo ^a   Kim, Boong Nyun ^a   Cho, Soo Churl ^a   Shin, Min Sup ^a   Kim, Jae Won ^a   Yoo, Hee Jeong ^b   Cho, Dae Yeon ^c   Chung, Un Sun ^d   Son, Jung Woo ^e   Kim, Hyo Won ^f  

^a Seoul National University Hospital   (South Korea)

^b Seoul National University Bundang Hospital   (South Korea)

^c LabGenomics Clinical Research Institute   (South Korea)

^d Kyungpook National University Hospital   (South Korea)

^e Chungbuk National University Hospital   (South Korea)

^f University of Ulsan College of Medicine   (South Korea)

Author keywords

Anxiety; Attention deficit hyperactivity disorder (ADHD); Continuous performance test; Genetic polymorphism; Transmission disequilibrium test

Indexed keywords

METABOTROPIC RECEPTOR 7; N METHYL DEXTRO ASPARTIC ACID; N METHYL DEXTRO ASPARTIC ACID 2A; N METHYL DEXTRO ASPARTIC ACID 2B; UNCLASSIFIED DRUG;

ARTICLE; ATTENTION DEFICIT DISORDER; CHILD; CHILDREN DEPRESSION INVENTORY; CLINICAL ASSESSMENT TOOL; CONTINUOUS PERFORMANCE TEST; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; KOREA; MAJOR CLINICAL STUDY; MALE; NEUROPSYCHOLOGICAL TEST; POPULATION BASED CASE CONTROL STUDY; PRIORITY JOURNAL; SCHOOL CHILD; STATE TRAIT ANXIETY INVENTORY FOR CHILDREN; TRANSMISSION DISEQUILIBRIUM TEST;

AFFECTIVE SYMPTOMS; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CASE-CONTROL STUDIES; CHILD; DATA INTERPRETATION, STATISTICAL; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; FEMALE; GENETIC ASSOCIATION STUDIES; GENOTYPE; GLUTAMIC ACID; HUMANS; LINKAGE DISEQUILIBRIUM; MALE; NEUROPSYCHOLOGICAL TESTS; POLYMORPHISM, GENETIC; PSYCHIATRIC STATUS RATING SCALES; PSYCHOMOTOR PERFORMANCE; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTORS, METABOTROPIC GLUTAMATE; REPUBLIC OF KOREA; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; WECHSLER SCALES;

EID: 84871876373     PISSN: None     EISSN: 17449081     Source Type: Journal    
DOI: 10.1186/1744-9081-9-1     Document Type: Article

References (52)

1. Polanczyk G, de Lima MS, Horta BL, Biederman J, Rohde LA. The worldwide prevalence of ADHD: a systematic review and metaregression analysis. Am J Psychiatry 2007, 164:942-948. 10.1176/appi.ajp.164.6.942, 17541055.
2. Franke B, Neale BM, Faraone SV. Genome-wide association studies in ADHD. Hum Genet 2009, 126:13-50. 10.1007/s00439-009-0663-4, 19384554.
3. Biederman J, Spencer T. Attention-deficit/hyperactivity disorder (ADHD) as a noradrenergic disorder. Biol Psychiatry 1999, 46:1234-1242. 10.1016/S0006-3223(99)00192-4, 10560028.
4. Pliszka SR, McCracken JT, Maas JW. Catecholamines in attention-deficit hyperactivity disorder: current perspectives. J Am Acad Child Adolesc Psychiatry 1996, 35:264-272. 10.1097/00004583-199603000-00006, 8714313.
5. Giros B, Jaber M, Jones SR, Wightman RM, Caron MG. Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter. Nature 1996, 379:606-612. 10.1038/379606a0, 8628395.
6. Jin Z, Zang YF, Zeng YW, Zhang L, Wang YF. Striatal neuronal loss or dysfunction and choline rise in children with attention-deficit hyperactivity disorder: a 1H-magnetic resonance spectroscopy study. Neurosci Lett 2001, 315:45-48. 10.1016/S0304-3940(01)02315-1, 11711211.
7. MacMaster FP, Carrey N, Sparkes S, Kusumakar V. Proton spectroscopy in medication-free pediatric attention-deficit/hyperactivity disorder. Biol Psychiatry 2003, 53:184-187. 10.1016/S0006-3223(02)01401-4, 12547476.
8. Courvoisie H, Hooper SR, Fine C, Kwock L, Castillo M. Neurometabolic functioning and neuropsychological correlates in children with ADHD-H: preliminary findings. J Neuropsychiatry Clin Neurosci 2004, 16:63-69. 10.1176/appi.neuropsych.16.1.63, 14990761.
9. Carrey N, MacMaster FP, Fogel J, Sparkes S, Waschbusch D, Sullivan S, Schmidt M. Metabolite changes resulting from treatment in children with ADHD: a 1H-MRS study. Clin Neuropharmacol 2003, 26:218-221. 10.1097/00002826-200307000-00013, 12897644.
10. DasBanerjee T, Middleton FA, Berger DF, Lombardo JP, Sagvolden T, Faraone SV. A comparison of molecular alterations in environmental and genetic rat models of ADHD: a pilot study. Am J Med Genet Part B, Neuropsychiatric Genet: Int Soc Psychiatr Genet 2008, 147B:1554-1563.
11. Sagvolden T, Johansen EB, Woien G, Walaas SI, Storm-Mathisen J, Bergersen LH, Hvalby O, Jensen V, Aase H, Russell VA, et al. The spontaneously hypertensive rat model of ADHD-the importance of selecting the appropriate reference strain. Neuropharmacology 2009, 57:619-626. 10.1016/j.neuropharm.2009.08.004, 2783904, 19698722.
12. Ozawa S, Kamiya H, Tsuzuki K. Glutamate receptors in the mammalian central nervous system. Prog Neurobiol 1998, 54:581-618. 10.1016/S0301-0082(97)00085-3, 9550192.
13. Riedel G, Platt B, Micheau J. Glutamate receptor function in learning and memory. Behav Brain Res 2003, 140:1-47. 10.1016/S0166-4328(02)00272-3, 12644276.
14. Nakanishi S. Metabotropic glutamate receptors: synaptic transmission, modulation, and plasticity. Neuron 1994, 13:1031-1037. 10.1016/0896-6273(94)90043-4, 7946343.
15. Pin JP, Duvoisin R. The metabotropic glutamate receptors: structure and functions. Neuropharmacology 1995, 34:1-26. 10.1016/0028-3908(94)00129-G, 7623957.
16. Flor PJ, Van Der Putten H, Ruegg D, Lukic S, Leonhardt T, Bence M, Sansig G, Knopfel T, Kuhn R. A novel splice variant of a metabotropic glutamate receptor, human mGluR7b. Neuropharmacology 1997, 36:153-159. 10.1016/S0028-3908(96)00176-1, 9144652.
17. Miyamoto Y, Yamada K, Noda Y, Mori H, Mishina M, Nabeshima T. Hyperfunction of dopaminergic and serotonergic neuronal systems in mice lacking the NMDA receptor epsilon1 subunit. J Neurosci 2001, 21:750-757.
18. Sakimura K, Kutsuwada T, Ito I, Manabe T, Takayama C, Kushiya E, Yagi T, Aizawa S, Inoue Y, Sugiyama H, et al. Reduced hippocampal LTP and spatial learning in mice lacking NMDA receptor epsilon 1 subunit. Nature 1995, 373:151-155. 10.1038/373151a0, 7816096.
19. Tang YP, Shimizu E, Dube GR, Rampon C, Kerchner GA, Zhuo M, Liu G, Tsien JZ. Genetic enhancement of learning and memory in mice. Nature 1999, 401:63-69. 10.1038/43432, 10485705.
20. Kutsuwada T, Sakimura K, Manabe T, Takayama C, Katakura N, Kushiya E, Natsume R, Watanabe M, Inoue Y, Yagi T, et al. Impairment of suckling response, trigeminal neuronal pattern formation, and hippocampal LTD in NMDA receptor epsilon 2 subunit mutant mice. Neuron 1996, 16:333-344. 10.1016/S0896-6273(00)80051-3, 8789948.
21. Adams J, Crosbie J, Wigg K, Ickowicz A, Pathare T, Roberts W, Malone M, Schachar R, Tannock R, Kennedy JL, Barr CL. Glutamate receptor, ionotropic, N-methyl D-aspartate 2A (GRIN2A) gene as a positional candidate for attention-deficit/hyperactivity disorder in the 16p13 region. Mol Psychiatry 2004, 9:494-499. 10.1038/sj.mp.4001455, 14699423.
22. Smalley SL, Kustanovich V, Minassian SL, Stone JL, Ogdie MN, McGough JJ, McCracken JT, MacPhie IL, Francks C, Fisher SE, et al. Genetic linkage of attention-deficit/hyperactivity disorder on chromosome 16p13, in a region implicated in autism. Am J Hum Genet 2002, 71:959-963. 10.1086/342732, 378550, 12187510.
23. Turic D, Langley K, Mills S, Stephens M, Lawson D, Govan C, Williams N, Van Den Bree M, Craddock N, Kent L, et al. Follow-up of genetic linkage findings on chromosome 16p13: evidence of association of N-methyl-D aspartate glutamate receptor 2A gene polymorphism with ADHD. Mol Psychiatry 2004, 9:169-173. 10.1038/sj.mp.4001387, 14966475.
24. Dorval KM, Wigg KG, Crosbie J, Tannock R, Kennedy JL, Ickowicz A, Pathare T, Malone M, Schachar R, Barr CL. Association of the glutamate receptor subunit gene GRIN2B with attention-deficit/hyperactivity disorder. Genes Brain Behav 2007, 6:444-452. 10.1111/j.1601-183X.2006.00273.x, 17010153.
25. Kinoshita A, Shigemoto R, Ohishi H, van der Putten H, Mizuno N. Immunohistochemical localization of metabotropic glutamate receptors, mGluR7a and mGluR7b, in the central nervous system of the adult rat and mouse: a light and electron microscopic study. J Comp Neurol 1998, 393:332-352. 10.1002/(SICI)1096-9861(19980413)393:3<332::AID-CNE6>3.0.CO;2-2, 9548554.
26. Kosinski CM, Risso Bradley S, Conn PJ, Levey AI, Landwehrmeyer GB, Penney JB, Young AB, Standaert DG. Localization of metabotropic glutamate receptor 7 mRNA and mGluR7a protein in the rat basal ganglia. J Comp Neurol 1999, 415:266-284. 10.1002/(SICI)1096-9861(19991213)415:2<266::AID-CNE9>3.0.CO;2-7, 10545164.
27. Callaerts-Vegh Z, Beckers T, Ball SM, Baeyens F, Callaerts PF, Cryan JF, Molnar E, D'Hooge R. Concomitant deficits in working memory and fear extinction are functionally dissociated from reduced anxiety in metabotropic glutamate receptor 7-deficient mice. J Neurosci 2006, 26:6573-6582. 10.1523/JNEUROSCI.1497-06.2006, 16775145.
28. Cryan JF, Kelly PH, Neijt HC, Sansig G, Flor PJ, van Der Putten H. Antidepressant and anxiolytic-like effects in mice lacking the group III metabotropic glutamate receptor mGluR7. Eur J Neurosci 2003, 17:2409-2417. 10.1046/j.1460-9568.2003.02667.x, 12814372.
29. Fendt M, Schmid S, Thakker DR, Jacobson LH, Yamamoto R, Mitsukawa K, Maier R, Natt F, Husken D, Kelly PH, et al. mGluR7 facilitates extinction of aversive memories and controls amygdala plasticity. Mol Psychiatry 2008, 13:970-979. 10.1038/sj.mp.4002073, 17712315.
30. Masugi M, Yokoi M, Shigemoto R, Muguruma K, Watanabe Y, Sansig G, van der Putten H, Nakanishi S. Metabotropic glutamate receptor subtype 7 ablation causes deficit in fear response and conditioned taste aversion. J Neurosci 1999, 19:955-963.
31. Mick E, Neale B, Middleton FA, McGough JJ, Faraone SV. Genome-wide association study of response to methylphenidate in 187 children with attention-deficit/hyperactivity disorder. Am J Med Genet Part B, Neuropsychiatric Genet: Int Soc Psychiatr Genet 2008, 147B:1412-1418.
32. Kim JW. Association study and population admixture. Human neurobehavioral genetics in the 21st century 2003, Seoul: Korean Society of Biological Psychiatry.
33. So YK, Noh JS, Kim YS, Ko SG, Koh YJ. The reliability and validity of Korean parent and teacher ADHD rating scale. J Korean Neuropsychiatr Assoc 2002, 41:283-289.
34. Oh KJ, Lee H, Hong KE, Ha EH. K-CBCL 1997, Seoul, Korea: Chung Ang Aptitude Publishing Co.
35. Park KS, Yoon JY, Park HJ, Park HJ, Kwon KU. Development of KEDI-WISC, individual intelligence test for Korean children 1996, Seoul: Korean Educational Development Institute.
36. Shaffer D, Fisher P, Lucas CP, Dulcan MK, Schwab-Stone ME. NIMH Diagnostic Interview Schedule for Children Version IV (NIMH DISC-IV): description, differences from previous versions, and reliability of some common diagnoses. J Am Acad Child Adolesc Psychiatry 2000, 39:28-38. 10.1097/00004583-200001000-00014, 10638065.
37. Cho SC, Kim BN, Kim JW, Kim HW, Choi HJ, Jung SW, Yang YH DSC, Go BJ, Kim BS, et al. The reliability and validity of diagnostic interview schedule for children version IV-Korean version (DISC-IV). J Korean Acad Child Adolesc Psychiatry 2006, 18:138-144.
38. Kaufman J, Birmaher B, Brent D, Rao U, Flynn C, Moreci P, Williamson D, Ryan N. Schedule for affective disorders and schizophrenia for school-age children-present and lifetime version (K-SADS-PL): initial reliability and validity data. J Am Acad Child Adolesc Psychiatry 1997, 36:980-988. 10.1097/00004583-199707000-00021, 9204677.
39. Kim YS, Cheon KA, Kim BN, Chang SA, Yoo HJ, Kim JW, Cho SC, Seo DH, Bae MO, So YK, et al. The reliability and validity of kiddie-schedule for affective disorders and schizophrenia-present and lifetime version- Korean version (K-SADS-PL-K). Yonsei Med J 2004, 45:81-89.
40. Greenberg LM, Waldman ID. Developmental normative data on the test of variables of attention (T.O.V.A.). J Child Psychol Psychiatry 1993, 34:1019-1030. 10.1111/j.1469-7610.1993.tb01105.x, 8408366.
41. Shin MS, Cho S, Chun SY, Hong KE. A study of the development and standardization of ADHD Diagnostic System. Korean J Child & Adol Psychiatr 2000, 11:91-99.
42. Kovacs M. The Children's Depression, Inventory (CDI). Psychopharmacol Bull 1985, 21:995-998.
43. Cho SC, Lee YS. Development of the Korean version of children's depression inventory. J Korean Neuropsychiatr Assoc 1990, 29:943-956.
44. Spielberger CD. Manual for the State-Trait Anxiety Inventory for Children 1972, Palo Alto, CA: Consulting Psychological Press.
45. Cho SC, Choi JS. Development of the Korean version of state-trait anxiety inventory for children. Seoul Rev Psychiatry 1989, 14:150-157.
46. Smalley SL. Genetic influences in childhood-onset psychiatric disorders: autism and attention-deficit/hyperactivity disorder. Am J Hum Genet 1997, 60:1276-1282. 10.1086/515485, 1716113, 9199546.
47. Bobb AJ, Addington AM, Sidransky E, Gornick MC, Lerch JP, Greenstein DK, Clasen LS, Sharp WS, Inoff-Germain G, Wavrant-De Vrieze F, et al. Support for association between ADHD and two candidate genes: NET1 and DRD1. Am J Med Genet Part B, Neuropsychiatric Genet: Int Soc Psychiatr Genet 2005, 134B:67-72.
48. Castellanos FX, Tannock R. Neuroscience of attention-deficit/hyperactivity disorder: the search for endophenotypes. Nat Rev Neurosci 2002, 3:617-628.
49. Oades RD. Differential measures of 'sustained attention' in children with attention-deficit/hyperactivity or tic disorders: relations to monoamine metabolism. Psychiatry Res 2000, 93:165-178. 10.1016/S0165-1781(00)00105-0, 10725533.
50. Szatmari P, Maziade M, Zwaigenbaum L, Merette C, Roy MA, Joober R, Palmour R. Informative phenotypes for genetic studies of psychiatric disorders. Am J Med Genet Part B, Neuropsychiatric Genet: Int SocPsychiatr Genet 2007, 144B:581-588.
51. Flint J, Munafo MR. The endophenotype concept in psychiatric genetics. Psychol Med 2007, 37:163-180. 10.1017/S0033291706008750, 2829981, 16978446.
52. Elia J, Glessner JT, Wang K, Takahashi N, Shtir CJ, Hadley D, Sleiman PM, Zhang H, Kim CE, Robison R, et al. Genome-wide copy number variation study associates metabotropic glutamate receptor gene networks with attention deficit hyperactivity disorder. Nat Genet 2012, 44:78-84.